Abstract
The African continent has some of the world’s lowest COVID-19 vaccination rates. While the limited availability of vaccines is a contributing factor, COVID-19 vaccine hesitancy among health care providers (HCP) is another factor that could adversely affect efforts to control infections on the continent. We sought to understand the extent of COVID-19 vaccine hesitancy among HCP, and its contributing factors in Africa. We evaluated COVID-19 vaccine hesitancy among 1,499 HCP enrolled in a repeated cross-sectional telephone survey in Burkina Faso, Ethiopia, Nigeria, Tanzania and Ghana. We defined COVID-19 vaccine hesitancy among HCP as self-reported responses of definitely not, maybe, unsure, or undecided on whether to get the COVID-19 vaccine, compared to definitely getting the vaccine. We used Poisson regression models to evaluate factors influencing vaccine hesitancy among HCP. Approximately 65.6% were nurses and the mean age (±SD) of participants was 35.8 (±9.7) years. At least 67% of the HCP reported being vaccinated. Reasons for low COVID-19 vaccine uptake included concern about vaccine effectiveness, side effects and fear of receiving unsafe and experimental vaccines. COVID-19 vaccine hesitancy affected 45.7% of the HCP in Burkina Faso, 25.7% in Tanzania, 9.8% in Ethiopia, 9% in Ghana and 8.1% in Nigeria. Respondents reporting that COVID-19 vaccines are very effective (RR:0.21, 95% CI:0.08, 0.55), and older HCP (45 or older vs.20-29 years, RR:0.65, 95% CI: 0.44,0.95) were less likely to be vaccine-hesitant. Nurses were more likely to be vaccine-hesitant (RR 1.38, 95% CI: 1.00,1.89) compared to doctors. We found higher vaccine hesitancy among HCP in Burkina Faso and Tanzania. Information asymmetry among HCP, beliefs about vaccine effectiveness and the endorsement of vaccines by the public health institutions may be important. Efforts to address hesitancy should address information and knowledge gaps among different cadres of HCP and should be coupled with efforts to increase vaccine supply.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by institutional support from Harvard T.H. Chan School of Public Health, Boston, MA Harvard University Center for African Studies, Boston, MA Heidelberg Institute of Global Health, Germany and the George Washington University Milken Institute of Public Health, Washington, DC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was obtained from the Institutional Review Board at Harvard T.H. Chan School of Public Health and ethical review boards in each country and site, including the Kintampo Health Research Centre Institutional Ethics Committee in Ghana the Nouna Health Research Center Ethical Committee and National Ethics Committee in Burkina Faso the Institutional Ethical Review Board of Addis Continental Institute of Public Health in Ethiopia the University of Ibadan Research Ethics Committee and National Health Research Ethics Committee in Nigeria and the Muhimbili University of Health and Allied Sciences and National Institute for Medical Research in Tanzania.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
ism313{at}mail.harvard.edu (IM); livesy.naafoe{at}uds.edu.gh (LNA)
Conflict of Interest and Funding Disclosure: No conflicts of interest are reported for all authors
Funding Source: This work was supported by institutional support from Harvard T.H. Chan School of Public Health, Boston, MA; Harvard University Center for African Studies, Boston, MA; Heidelberg Institute of Global Health, Germany and the George Washington University Milken Institute of Public Health, Washington, DC.
Data sharing: Individual participant data collected for this study may be shared based on a reasonable request to the corresponding authors.
Data Availability
Individual participant data collected for this study may be shared based on a reasonable request to the corresponding authors.
Abbreviations
- ARISE African Research
- Implementation Science and Education network
- COVID-19
- Coronavirus disease 2019
- HCP
- Health Care Providers
- PPE
- personal protective equipment
- SSA
- sub-Saharan Africa
